Format

Send to

Choose Destination
See comment in PubMed Commons below
Can J Infect Dis. 1998 Mar;9(2):99-108.

T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Author information

1
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba.

Abstract

Chlamydia trachomatis is an obligate intracellular bacterial pathogen that causes several significant human infectious diseases, including trachoma, urethritis, cervicitis and salpingitis, and is an important cofactor for transmission of human immunodeficiency virus. Until very recently, over three decades of research effort aimed at developing a C trachomatis vaccine had failed, due mainly to the lack of a precise understanding of the mechanisms for protective immunity. Although most studies concerning protective immunity to C trachomatis have focused on humoral immune responses, recent studies have clearly shown that T helper-1 (Th1)-like CD4 T cell-mediated immune responses play the dominant role in protective immunity. These studies suggest a paradigm for chlamydial immunity and pathology based on the concept of heterogeneity (Th1/Th2) in CD4 T cell immune responses. This concept for chlamydial immunity offers a rational template on which to base renewed efforts for development of a chlamydial vaccine that targets the induction of cell-mediated Th1 immune responses.

KEYWORDS:

Cell-mediated immunity; Chlamydia trachomatis; Cytokine; Th1/Th2; Vaccine

PMID:
22451777
PMCID:
PMC3307538
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center